CLINUVEL PHARMACEUTICALS LTD

10.850

+0.1501.40%

Volume:79.62K

Turnover:855.15K

Market Cap:542.61M

PE:14.10

High:10.850

Open:10.750

Low:10.500

Close:10.700

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-0.75%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CUV.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":10.85,"timestamp":1744870320000,"preClose":10.7,"halted":0,"volume":79617,"delay":0,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41307998,"shares":50009750,"eps":0.769445,"marketStatus":"Not Yet Opened","change":0.15,"latestTime":"04-17 16:12:00 AEST","open":10.75,"high":10.85,"low":10.5,"amount":855154,"amplitude":0.03271,"askPrice":10.85,"askSize":489,"bidPrice":10.7,"bidSize":93,"shortable":3,"etf":0,"ttmEps":0.769445,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":10.7,"dividendRate":0.004608,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0.681300081588836,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41307998,"roa":"14.22%","roe":"19.59%","lyrEps":0.7151,"volumeRatio":0.681300081588836,"shares":50009750,"dividePrice":0.05,"high":10.85,"amplitude":0.03271,"preClose":10.7,"low":10.5,"week52Low":9.755,"pbRate":"2.50","psRate":"5.96","week52High":17.652,"institutionHeld":0,"latestPrice":10.85,"committee":-0.680412,"eps":0.769445,"divideRate":0.004608,"volume":79617,"delay":0,"ttmEps":0.769445,"open":10.75,"prevYearClose":12.06,"prevWeekClose":10.85,"prevMonthClose":11.46,"prevQuarterClose":11.46,"fiveDayClose":10.86,"twentyDayClose":11.88,"sixtyDayClose":11.71},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CUV.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.007524}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527714507","title":"High Growth Tech Stocks To Watch In April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527714507","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527714507?lang=en_us&edition=fundamental","pubTime":"2025-04-15 03:35","pubTimestamp":1744659336,"startTime":"0","endTime":"0","summary":"The Australian market showed strength on Monday, with the IT sector leading gains by 2.6%, buoyed by positive momentum from Wall Street and a rise in materials driven by higher iron ore and gold prices. In this environment, identifying high growth tech stocks involves looking for companies that are capitalizing on current market trends and demonstrating resilience during earnings season, as they can potentially offer significant opportunities for investors seeking exposure to innovative sectors.Click here to see the full list of 48 stocks from our ASX High Growth Tech and AI Stocks screener.Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and internationally; it has a market cap of A$536.43 million.Operations: Clinuvel Pharmaceuticals generates revenue primarily from its biopharmaceutical sector, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-watch-193536682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IFM.AU","BK7508","BK7067","XAO.AU","BK7016","SDR.AU","XKO.AU","XJO.AU","BK7503","CUV.AU"],"gpt_icon":0},{"id":"2522235477","title":"Clinuvel Pharmaceuticals to Buy Back Up to 1.5 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2522235477","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522235477?lang=en_us&edition=fundamental","pubTime":"2025-03-27 06:30","pubTimestamp":1743028235,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) said it will repurchase a maximum of 1.5 million ordinary fully-paid shares as part of an on-market buyback, according to a Thursday Australian bourse filing.The repurchases are expected to start on April 10 and will run for 12 months, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","CUV.AU","XKO.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2522351474","title":"BRIEF-Clinuvel Pharmaceuticals Renews Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2522351474","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522351474?lang=en_us&edition=fundamental","pubTime":"2025-03-27 06:04","pubTimestamp":1743026647,"startTime":"0","endTime":"0","summary":"BRIEF-Clinuvel Pharmaceuticals Renews Share Buy-Back ProgramMarch 27 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:RENEWS SHARE BUY-BACK PROGRAMREPURCHASE OF UP TO 1.5 MILLION ORDINARY SHARESFurther company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUV.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2522735111","title":"Clinuvel Pharmaceuticals Ltd - Renews Share Buy-Back Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2522735111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522735111?lang=en_us&edition=fundamental","pubTime":"2025-03-27 06:03","pubTimestamp":1743026594,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CUV.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":14,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"},{"date":"2024-08-29","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-02-22","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":"2023-08-29","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Clinuvel Pharmaceuticals Ltd","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}]}}